loading page

Effect of outcome measures on the apparent efficacy of ablation for atrial fibrillation: Why “success” is an inappropriate term
  • +6
  • Nick Jackson,
  • Ehsan Mahmoodi,
  • James Leitch,
  • Malcolm Barlow,
  • Allan Davies,
  • Nicholas Collins,
  • Lucy Leigh,
  • Christopher Oldmeadow,
  • Andrew Boyle
Nick Jackson
John Hunter Hospital

Corresponding Author:[email protected]

Author Profile
Ehsan Mahmoodi
The University of Newcastle
Author Profile
James Leitch
John Hunter Hospital
Author Profile
Malcolm Barlow
John Hunter Hospital
Author Profile
Allan Davies
John Hunter Hospital
Author Profile
Nicholas Collins
John Hunter Hospital
Author Profile
Lucy Leigh
The University of Newcastle
Author Profile
Christopher Oldmeadow
The University of Newcastle
Author Profile
Andrew Boyle
John Hunter Hospital
Author Profile

Abstract

INTRODUCTION: Different endpoint criteria, different durations of follow up and the completeness of follow up can dramatically affect the perceived benefits of Atrial Fibrillation (AF) ablation. METHODS: We defined three endpoints for recurrence of AF post ablation in a cohort of 200 patients with symptomatic AF, refractory to antiarrhythmic drugs (AADs). A “Strict Endpoint” where patients were considered to have a recurrence with any symptomatic or documented recurrence for ≥30 seconds with no blanking period, and off their AADs, a “Liberal Endpoint” where only documented recurrences after the blanking period, either on or off AADs were counted, and “Liberal Endpoint + Redo” which was the same as the Liberal endpoint but allowing for 1 redo ablation or 1 cardioversion (DCCV) during follow up. We also surveyed 50 patients on the waiting list for an AF ablation and asked them key questions regarding what they would consider to be a successful result for them. RESULTS: Freedom from recurrence of atrial tachyarrhythmias (AT) at 5 years was 62% for the strict endpoint, 73% for the liberal endpoint, and 80% for the liberal endpoint + redo group (p<0.001). Of the 50 patients surveyed awaiting AF ablation, 70% said they would still consider the procedure a success if it required one repeat ablation or one DCCV (p=0.004), and 76% would be accepting of one or two recurrences during follow-up (p<0.001). CONCLUSION: In this study the most important predictor of AT recurrence following AF ablation was the criteria used to define recurrence.
Aug 2021Published in Heart, Lung and Circulation volume 30 issue 8 on pages 1166-1173. 10.1016/j.hlc.2021.01.013